Eric Roberts

Sep 9, 2024 | healio.com | Justin Cooper |Shenaz Bagha |Eric Roberts

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The availability of just one or two biosimilars for a given drug may not be enough to increase uptake. Medicare uptake continued to lag for up to 2 years even after a third biosimilar was available.

Feb 10, 2024 | healio.com | Rob Volansky |Shenaz Bagha |Vibeke Strand |Eric Roberts

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A lot can change in a year. But has it? The first Humira biosimilar hit the U.S. market a little over a year ago.